FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

927 letters match. Newest first.

  1. Advanced Pharmaceutical Technology

    FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.

    High risk
  2. Neva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi

    FDA warns Turkish OTC drug maker Neva Global over inadequate component testing, process validation, stability, and quality oversight.

    High risk
  3. International Laboratories Corp

    FDA warned International Laboratories Corp, a Thai drug manufacturer, over fabricated lab records and inadequate CGMP controls.

    High risk
  4. Mehran Michael Bahrami, M.D.

    FDA warns clinical investigator Dr. Mehran Michael Bahrami over protocol violations and missing records in investigational drug trials.

    High risk
  5. Zacanta LLC

    Zacanta LLC lacked an FSVP for fresh beans and carrots imported from Mexico, FDA says.

    Medium
  6. Red Oak Instruments, LLC

    Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.

    High risk
  7. Rite-Kem Incorporated

    FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.

    High risk
  8. Vegewax Candleworx Ltd.

    FDA warns Vegewax Candleworx over CGMP violations in OTC drug manufacturing, including inadequate component testing and OOS investigations.

    High risk
  9. Shree Jaya Laboratories PVT. LTD.

    FDA warned Shree Jaya Laboratories after an inspection found CGMP deviations in API and intermediate manufacturing, including dirty equipment and torn batch records.

    High risk
  10. Linghai ZhanWang Biotechnology Co., Ltd

    Linghai ZhanWang Biotechnology's OTC drugs, including antimicrobial wipes, fail manufacturing quality rules; FDA cites missing tests.

    High risk
  11. Granules India Limited

    FDA warned Granules India in Telangana, India, that its finished drugs are adulterated after inspectors found cross-contamination in air ducts, bird droppings and torn records.

    High risk
  12. Garcia Fresh Vegetables LLC

    FDA warned Garcia Fresh Vegetables for lacking a Foreign Supplier Verification Program for all imported foods after a December 2024 inspection.

    Medium
  13. Radhaswamy Inc. dba Raja Foods LLC

    FDA warned Radhaswamy Inc. dba Raja Foods that it lacked required foreign supplier verification for most imported foods, including rice and candy.

    High risk
  14. Zenzi Pharmaceutical Industries Pvt. Ltd.

    Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.

    High risk
  15. ABR Laboratory LLC

    FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.

    High risk
  16. Tyche Industries Ltd

    FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.

    High risk
  17. Jagsonpal Pharmaceuticals Limited

    Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.

    High risk
  18. Robbins Instruments, LLC

    Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.

    High risk
  19. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk
  20. Shantou Kangjie Daily Chemical Industry Co., Ltd

    FDA warns Shantou Kangjie over CGMP failures for OTC drugs, including untested ethanol and no quality unit.

    High risk
  21. Imperial Palace Commodity -Dongguan- Co., Ltd.

    FDA warns Chinese maker of OTC alcohol wipes that weak component testing and process validation make its drugs adulterated.

    High risk
  22. Center for Instrumental Analysis of China Pharmaceutical University

    Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.

    High risk
  23. Global Calcium Pvt. Limited

    FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.

    High risk
  24. Talla Imports, LLC

    FDA says Talla Imports lacked required foreign supplier safety plans for Swedish toffee, cookies and candy.

    Medium
  25. Kardesler Ucan Yaglar Sanayi Anonim Sirketi

    Turkey-based OTC drug maker Kardesler Ucan failed to test glycerin, propylene glycol and ethanol for dangerous impurities and is on US import alert.

    High risk
  26. Chara Biologics, Inc.

    FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.

    High risk
  27. Nyumbani Hakuna Matata LLC

    FDA warns Buffalo seafood importer Nyumbani Hakuna Matata over missing safety checks for dried fish from Tanzania.

    High risk
  28. COFISA - Conservas de Peixe da Figueira, S.A.

    FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

    High risk
  29. Premium Fresh Growers LLC

    FDA warns Premium Fresh Growers it lacked required foreign supplier checks for imported limes, cilantro, and carrots.

    Medium
  30. Duong Ha Processing Trading Seafood Company Limited

    FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.

    High risk
  31. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  32. By George Food Specialties Inc.

    By George Food Specialties lacked required foreign supplier verification program for imported mayonnaise and hot sauce, FDA says.

    Medium
  33. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.

    High risk
  34. Xoran Technologies, LLC

    FDA warned Xoran Technologies that its computed tomography devices and software violate quality rules and lack required marketing clearance.

    High risk
  35. Candymar Produce Inc

    Candymar Produce, a Texas importer, had no FSVP for imported carrots, squash and cabbage, FDA found.

    Medium
  36. Viatris, Inc.

    FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.

    High risk
  37. Akron Formulations India Private Limited

    Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.

    High risk
  38. Brands International Corporation

    Brands International, a Canadian drug manufacturer, limited an FDA inspection and had manufacturing quality violations including mold contamination.

    High risk
  39. Loyd Sanabria Hernandez dba Avicola Santa Fe

    FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.

    High risk
  40. Rontis Hellas S.A.

    Rontis Hellas made Cronus HP PTA balloon catheters with an unproven EtO sterilization process and inadequate US adverse-event reporting procedures.

    High risk
  41. Micro Orgo Chem

    Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.

    High risk
  42. Mid America Pet Food LLC

    FDA warned Mid America Pet Food after Salmonella-linked recalls and found persistent contamination and animal-food safety-rule violations at its Texas plant.

    High risk
  43. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  44. Guangzhou Four E’s Scientific Co., Ltd.

    FDA warns Guangzhou Four E’s over CGMP failures for OTC drugs, including a sterile-labeled product with inadequate sterility assurance.

    High risk
  45. Purcell International

    Purcell International imported cinnamon apple sauce linked to lead contamination without adequate foreign supplier verification.

    High risk
  46. WANABANA USA LLC

    WanaBana USA LLC failed to verify foreign supplier safety for lead-contaminated apple cinnamon puree pouches.

    High risk
  47. Caribbean Produce Exchange, LLC

    Caribbean Produce Exchange lacked required foreign supplier verification records for imported WanaBana apple cinnamon puree linked to lead recall.

    High risk
  48. Knickerbocker 365 Inc.

    FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.

    High risk
  49. Applied Therapeutics, Inc.

    Applied Therapeutics, a trial sponsor, failed to let FDA access deleted electronic trial data and omitted dosing-error information from its drug application.

    High risk
  50. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk